title: Exploring patients' reasons for discontinuance of heart medications.
abstract: BACKGROUND
  Despite the importance of secondary prevention, nonadherence rates for patients with myocardial infarction (MI) range from 13% to 60% for prescribed, evidence-based medicines. Although rates and consequences of discontinuance vary for different medications, the existing literature provides little insight into reasons for discontinuance.
  
  
  OBJECTIVE
  To address this gap, we explored clopidogrel and cholesterol-lowering therapy (CLT) discontinuance after an MI to understand patients' reasons for stopping these 2 medications.
  
  
  METHODS
  In this qualitative descriptive study, 2 groups of patients who stopped a heart medication-either clopidogrel or CLT-were recruited from a prospective MI registry. Patients who discontinued CLT (n = 29) or clopidogrel (n = 11) were interviewed within 18 months of hospitalization. Patients were recruited and interviewed until data saturation was achieved. The Health Belief Model was used as an organizing framework in analyzing and coding the narrative data. The codes were then summarized for each group and compared to identify similarities and differences in reasons for CLT and clopidogrel discontinuance.
  
  
  CONCLUSIONS
  The most common reason for CLT discontinuance was adverse effects that were painful and interfered with daily life. Less common reasons for discontinuance were prescription confusion, cost, mistrust in medicines/healthcare system, and preference for alternative therapies. Reasons for clopidogrel discontinuance were duration confusion, adverse effects, and cost. Although doctors stopped patients' clopidogrel in preparation for surgery, doctors conceded to discontinuance of CLT for patients who experienced adverse effects after trying 2 to 3 different CLTs. Patients who discontinued CLT were more likely to believe that they did not need the treatment than do patients who discontinued clopidogrel. Clinicians should be aware that reasons may vary across patients and medication class for prematurely stopping therapy; thus, proactive interventions should be targeted to address these differences. Identifying at-risk patients for targeted interventions to prevent premature cardiac medication discontinuation is vital.
authors.affiliation: Department of Psychology, University of Missouri-Kansas City, Kansas City, MO, USA.
authors.forename: Linda
authors.initials: L
authors.lastname: Garavalia
authors.forename: Brian
authors.initials: B
authors.lastname: Garavalia
authors.forename: John A
authors.initials: JA
authors.lastname: Spertus
authors.forename: Carole
authors.initials: C
authors.lastname: Decker
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000191:economics; D000077144:Clopidogrel; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence / Q000523:psychology*; D008875:Middle Aged; D008960:Models, Psychological; D009042:Motivation; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology*; D033262:Narration; D009730:Nursing Assessment; D015404:Nursing Methodology Research; D010353:Patient Education as Topic; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000191:economics; D036301:Qualitative Research; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000191:economics; D014481:United States / Q000453:epidemiology; D016903:Drug Monitoring
chemical_list: D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine
references.citation: J Am Coll Cardiol. 2007 May 1;49(17):1753-62
references.pmid: 17466224
references.citation: Int Heart J. 2008 Mar;49(2):135-42
references.pmid: 18475013
references.citation: Int J Cardiol. 2008 Dec 17;131(1):97-104
references.pmid: 18222551
references.citation: J Gen Intern Med. 2004 Jun;19(6):638-45
references.pmid: 15209602
references.citation: Crit Care Nurse. 2008 Oct;28(5):54-64; quiz 65
references.pmid: 18827087
references.citation: Am Heart J. 2006 Jan;151(1):185-91
references.pmid: 16368315
references.citation: Arch Intern Med. 2006 Sep 25;166(17):1842-7
references.pmid: 17000940
references.citation: Arch Intern Med. 2005 Sep 12;165(16):1842-7
references.pmid: 16157827
references.citation: Health Educ Q. 1984 Spring;11(1):1-47
references.pmid: 6392204
references.citation: J Cardiovasc Nurs. 2008 Sep-Oct;23(5):414-21
references.pmid: 18728514
references.citation: Circulation. 2006 Jan 17;113(2):203-12
references.pmid: 16401776
references.citation: Pharmacotherapy. 2001 Jul;21(7):828-41
references.pmid: 11444579
references.citation: Ann Pharmacother. 2005 Nov;39(11):1792-7
references.pmid: 16204391
references.citation: Circulation. 2006 Jun 20;113(24):2803-9
references.pmid: 16769908
references.citation: Ann Pharmacother. 2007 Nov;41(11):1805-11
references.pmid: 17925498
references.citation: Circulation. 2003 Oct 7;108(14):1682-7
references.pmid: 14504182
references.citation: N Engl J Med. 1995 Apr 27;332(17):1125-31
references.pmid: 7700285
references.citation: Am J Med. 2004 Jul 15;117(2):73-81
references.pmid: 15234641
references.citation: JAMA. 2007 Feb 28;297(8):831-41
references.pmid: 17327525
references.citation: Circulation. 2006 May 16;113(19):2363-72
references.pmid: 16702489
references.citation: Ann Pharmacother. 2002 Oct;36(10):1532-9
references.pmid: 12243601
references.citation: Arch Intern Med. 2006 Sep 25;166(17):1855-62
references.pmid: 17000942
references.citation: Prog Cardiovasc Nurs. 2000 Summer;15(3):97-103
references.pmid: 10951951
references.citation: Arch Intern Med. 2007 Apr 23;167(8):847-52
references.pmid: 17452550
references.citation: Arch Intern Med. 1999 Aug 9-23;159(15):1793-802
references.pmid: 10448784
references.citation: Med J Aust. 1996 Feb 19;164(4):208-11
references.pmid: 8604188
references.citation: J Cardiovasc Nurs. 2008 May-Jun;23(3):250-7
references.pmid: 18437067
references.citation: Circulation. 2007 Feb 13;115(6):813-8
references.pmid: 17224480
references.citation: BMJ. 2000 Oct 21;321(7267):983-6
references.pmid: 11039962
references.citation: J Cardiovasc Nurs. 2007 Nov-Dec;22(6):459-65
references.pmid: 18090186
references.citation: Qual Health Res. 2003 Jul;13(6):781-820
references.pmid: 12891715
references.citation: N Engl J Med. 2005 Aug 4;353(5):487-97
references.pmid: 16079372